Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer

NCT03579771 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Resectable Cholangiocarcinoma
Stage IB Intrahepatic Cholangiocarcinoma AJCC v8
Stage II Intrahepatic Cholangiocarcinoma AJCC v8
Stage III Intrahepatic Cholangiocarcinoma AJCC v8
Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8
Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8

Interventions

DRUG: Cisplatin
DRUG: Gemcitabine
DRUG: Nab-paclitaxel

Sponsor

Emory University

Collaborators

[object Object]
[object Object]
[object Object]